Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Tolosa-Vilella, C
- Morera-Morales, ML
- Simeon-Aznar, CP
- Mari-Alfonso, B
- Colunga-Arguelles, D
- Rubio, JLC
- Rubio-Rivas, M
- Freire-Dapena, M
- Guillen-del Castillo, A
- Iniesta-Arandia, N
- Castillo-Palma, MJ
- Egurbide-Arberas, M
- Trapiellla-Martinez, L
- Vargas-Hitos, JA
- Rodriguez-Carballeira, M
- Marin-Ballve, A
- Pla-Salas, X
- Rios-Blanco, JJ
- Fonollosa-Pla, V
- RESCLE Investigators
- Autoimmune Dis Study Grp GEAS
Grupos
Abstract
Objective: Digital ulcers (DU) are the most common vascular complication of systemic sclerosis (SSc). We compared the characteristics between patients with prior or current DU with those never affected and evaluated whether a history of DU may be a predictor of vascular, organ involvement, and/or death in patients with SSc. Methods: Data from SSc patients with or without prior or current DU were collected by 19 referral centers in an ongoing registry of Spanish SSc patients, named Registro de ESCLErodermia (RESCLE). Demographics, organ involvement, autoimmunity features, nailfold capillary pattern, survival time, and causes of death were analyzed to identify DU related characteristics and survival of the entire series and according to the following cutaneous subsets diffuse cutaneous SSc (dcSSc), limited cutaneous SSc (lcSSc), and SSc sine scleroderma (ssSSc). Results: Out of 1326, 552 patients enrolled in the RESCLE registry had prior or current DU, 88% were women, the mean age was 50 +/- 16 years, and the mean disease duration from first SSc symptom was 7.6 +/- 9.6 years. Many significant differences were observed in the univariate analysis between patients with and without prior/current DU. Multivariate analysis identified that history of prior/current DU in patients with SSc was independently associated to younger age at SSc diagnosis, diffuse cutaneous SSc, peripheral vascular manifestations such Raynaud's phenomenon, telangiectasia, and acro-osteolysis but no other vascular features such as pulmonary arterial hypertension or scleroderma renal crisis. DU was also associated to calcinosis cutis, interstitial lung disease, as well as worse survival. Multivariate analysis performed in the cutaneous subsets showed that prior/current DU were independently associated: (1) in dcSSc, to younger age at SSc diagnosis, presence of telangiectasia and calcinosis and rarely a non-SSc pattern on nailfold capillaroscopy; (2) in lcSSc, to younger age at SSc diagnosis, presence of Raynaud's phenomenon as well as calcinosis cutis, interstitial lung disease, and higher incidence of death from all causes; and (3) in ssSSc, to younger age at first SSc symptom and greater incidence of death from all causes. Conclusions: Digital ulcers develop in patients with SSc younger at diagnosis, mainly in patients with dcSSc and IcSSc, and they are associated to other peripheral vascular manifestations such as Raynaud's phenomenon, telangiectasia, and acro-osteolysis but also to calcinosis, and interstitial lung disease. History of DU in SSc leads to worse survival, also noticeable for lcSSc and ssSSc subsets but not for dcSSc patients. (C) 2016 Elsevier Inc. All rights reserved.
Datos de la publicación
- ISSN/ISSNe:
- 0049-0172, 1532-866X
- Tipo:
- Review
- Páginas:
- 200-208
- PubMed:
- 27312381
- Factor de Impacto:
- 1,983 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
SEMINARS IN ARTHRITIS AND RHEUMATISM W B SAUNDERS CO-ELSEVIER INC
Citas Recibidas en Web of Science: 32
Documentos
- No hay documentos
Filiaciones
Keywords
- Systemic sclerosis; Limited cutaneous SSc; Diffuse cutaneous SSc; SSc sine scleroderma; Digital ulcers; Anti-centromere antibodies; Anti-topoisomerase I antibodies; Nailfold capillaroscopy; Survival
Proyectos y Estudios Clínicos
ENSAYO MULTICÉNTRICO, ABIERTO Y CON UN SOLO GRUPO PARA EVALUAR LA EFICACIA, LA FARMACOCINÉTICA, LA SEGURIDAD Y LA TOLERABILIDAD DE IGSC AL 20 % EN SUJETOS CON INMUNODEFICIENCIA PRIMARIA.
Investigador Principal: PEDRO MORAL MORAL
GTI 1503 . 2017
PREVENCIÓN DE EPISODIOS DE TROMBOEMBOLIA - REGISTRO EUROPEO SOBRE TROMBOEMBOLIA VENOSA.
Investigador Principal: JOSÉ ANTONIO TODOLÍ PARRA
DAI-VTE-2013-02 . 2014
ENSAYO CLINICO FASE III, DE GRUPOS PARALELOS, RANDOMIZADO, CONTROLADO CON PLACEBO, DOBLE CIEGO Y MULTICENTRICO, PARA EVALUAR LA EFICACIA Y SEGURIDAD DE LA ADMINISTRACION DE TOCILIZUMAB EN PACIENTES DIAGNOSTICADOS DE ORBITOPATÍA TIROIDEA (OT) MODERADA A SE VERA O QUE AMENAZA LA VISTA, QUE NO HAN RESPONDIDO ADECUADAMENTE AL TRATAMIENTO CON PULSOS DE CORTICOIDES.
Investigador Principal: ENRIQUE ESPAÑA GREGORI
GRC-TCL-2010-01 . 2013
Cita
Tolosa C,Morera ML,Simeon CP,Mari B,Colunga D,Rubio JLC,Rubio M,Freire M,Guillen A,Iniesta N,Castillo MJ,Egurbide M,Trapiellla L,Vargas JA,Todoli JA,Rodriguez M,Marin A,Pla X,Rios JJ,Fonollosa V,RESCLE I,Autoimmune Dis Study GEAS GRP. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry. Semin Arthritis Rheum. 2016. 46(2):p. 200-208. IF:4,498. (1).